Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study.

Fiche publication

Date publication

octobre 2016

Journal

BMC cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BACHELLIER Philippe , Pr BORG Christophe , Dr FEIN Francine , Pr HEYD Bruno , Dr VERNEREY Dewi , Dr KIM Stephano , Dr VUITTON Lucine , Dr LAKKIS Zaher

Tous les auteurs :
d'Engremont C, Vernerey D, Pointet AL, Simone G, Fein F, Heyd B, Koch S, Vuitton L, Kim S, Jary M, Lamfichek N, Turco C, Lakkis Z, Berger A, Bonnetain F, Taieb J, Bachellier P, Borg C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27782813

Résumé

Pancreatic adenocarcinoma (PDAC) incidence is increasing worldwide. Several studies have shown that lymphopenia was correlated with a poor prognosis but the potential interest to measure lymphopenia in the pre and post-operative setting as well as its added value among conventional prognostic factors was never investigated.